Carlyle invests $250 million in U.S. e-commerce firm Pharmapacks
Reuters
Published Nov 12, 2020 06:17AM ET
By Chibuike Oguh
(Reuters) - Private equity firm Carlyle Group (NASDAQ:CG) Inc said on Thursday it had invested more than $250 million in Pharmapacks, a U.S. e-commerce firm focused on health, personal care and beauty products.
Carlyle's investment, which values Pharmapacks at about $1.1 billion, comes as the COVID-19 pandemic has pushed more consumers to shop online.
Founded as a brick-and-mortar pharmacy shop in 2010, Pharmapacks has grown into an online retailer for health and consumer goods giants such as Reckitt Benckiser Group, Bayer AG (DE:BAYGN), and L'Oreal SA.
Hauppauge, New York-based Pharmapacks generated about $250 million in sales last year by selling products mainly through large e-commerce marketplaces, including Amazon (NASDAQ:AMZN), eBay (NASDAQ:EBAY), Google (NASDAQ:GOOGL), Facebook (NASDAQ:FB), Walmart (NYSE:WMT) and Target (NYSE:TGT).
Pharmapacks aims to use the investment to open a new supply chain hub on the U.S. West Coast, expand its technology capabilities, and add more products in categories such as food and pets, its Chief Executive Andrew Vagenas said in an interview.
The investment in Pharmapacks was made out Carlyle Partners VII, a $18.5 billion buyout fund the firm recently used to acquire a $175 million stake in digital healthcare firm Grand Rounds Inc.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.